Meet with BIOVECTRA at the International mRNA Health Conference 2024
Boston, MA | November 12-14, 2024

Schedule a meeting with us at this year's International mRNA Health Conference and discover how BIOVECTRA can help with your mRNA manufacturing needs. BIOVECTRA's state-of-the-art Biomanufacturing and Vaccine Center has the:

• Capability to develop and manufacture plasmid DNA, mRNA, LNP formulations, and fill/finish
• Ability to produce up to 160 million doses of mRNA vaccines per year with scales ranging from mL to 30 L
• Capacity to prepare and package 70 million fill/finish doses per year for commercial distribution

BIOVECTRA is a North American CDMO specializing in the clinical-to-commercial scale production of high-quality regulated APIs and intermediates, including: 

• Custom lipids
• Biologics
• pDNA, mRNA, LNP manufacturing
• Synthetic small molecules
• Fermented small molecules
• Highly potent APIs
• Bioreagents
• Fill/Finish

Our team – backed by 50+ years of experience – looks forward to the opportunity to put our flexible, innovative manufacturing solutions at your disposal.

 

Schedule a meeting with us and discover how we can support your  projects and solve your most complex challenges.

 

---

Stay connected with us